MPAY:NYE-Akros Monthly Payout ETF (USD)

ETF | Others |

Last Closing

USD 25.243

Change

0.00 (0.00)%

Market Cap

USD 3.81M

Volume

1.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund normally invests in securities comprising the index. The index generally consists of 18 exchange-traded funds ("ETFs") and 50 U.S. exchange-listed stocks (the "Equity Portfolio Sleeve"), though this may change from time to time. It may invest up to 20% of its assets in investments that are not included in the index, but that the Adviser believes will help the fund track the performance of the index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing MPAY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.66% 54% F 57% F
Dividend Return 6.80% 90% A- 84% B
Total Return 16.46% 68% D+ 64% D
Trailing 12 Months  
Capital Gain 15.50% 56% F 56% F
Dividend Return 8.32% 90% A- 84% B
Total Return 23.82% 68% D+ 63% D
Trailing 5 Years  
Capital Gain N/A 96% N/A 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 96% N/A 100% F
Average Annual (5 Year Horizon)  
Capital Gain 50,828.34% 100% F 100% F
Dividend Return 50,830.51% 100% F 100% F
Total Return 2.17% 76% C+ 51% F
Risk Return Profile  
Volatility (Standard Deviation) 88,286.13% N/A F N/A F
Risk Adjusted Return 57.57% 69% C- 74% C
Market Capitalization 3.81M 8% B- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.